{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:25:55Z","timestamp":1767965155789,"version":"3.49.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>To analyze the correlation between IGF-1, ZAG, nesfatin-1, HbA1c levels, and type 2 diabetes mellitus (T2DM) complicated with hypothyroidism.<\/jats:p>\n            <jats:p>Fifty-five patients with type-2 diabetes who were admitted to our hospital from August 2018 to February 2020 were selected as the control group, and 55 patients with type 2 diabetes combined with hypothyroidism who were admitted to the hospital at the same period were selected as the combined group, and 56 patients who came to our hospital for physical examination at the same period were selected as the healthy group. The general clinical data and relevant laboratory indexes of all patients in the three groups were collected and statistically analyzed. Besides, the correlation between IGF-1, ZAG, nesfatin-1, HbA1c levels, and T2DM complicated with hypothyroidism was analyzed.<\/jats:p>\n            <jats:p>Levels of FPG, FINS, TC, TG, LDL, 2hPBG, TPOAb, TgAb, and HOMA-IR in the diabetes group and combined group were all significantly higher than those in the healthy group, while HDL and T4 levels in the diabetes group and combined group were lower than those in the healthy group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). The levels of FPG, FINS, TC, TG, LDL, 2hPBG, TPOAb, and TgAb in the combined group were significantly higher than those in the diabetes group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05), and the levels of HDL and T4 were lower than those in the diabetes group. In addition, the IGF-1 level was positively correlated with ZAG, nesfatin-1, and HbA1c levels in the combined group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05), and IGF-1 (OR: 0.964, 95% CI: 0.943\u20130.983, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.001), ZAG (OR: 1.298, 95% CI: 1.121\u20131.401, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.005), nesfatin-1 (OR: 0.876, 95% CI: 0.751\u20130.901, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.002), and HbA1c (OR: 1.321, 95% CI: 1.121\u20131.401, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.012) were independent risk factors for T2DM complicated with hypothyroidism.<\/jats:p>\n            <jats:p>Regular detection of IGF-1, ZAG, nesfatin-1, and HbA1c levels are of great value for the diagnosis and treatment of patients with T2DM complicated with hypothyroidism.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025432","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T19:48:42Z","timestamp":1618343322000},"page":"e25432","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Correlation analysis of IGF-1, ZAG, nesfatin-1, HbA1c levels, and type 2 diabetes mellitus complicated with hypothyroidism"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7876-9683","authenticated-orcid":false,"given":"Shuangling","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenghua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2013.168118","article-title":"2010 China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults [J]","volume":"310","author":"Xu","year":"2013","journal-title":"JAMA"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1210\/er.2018-00163","article-title":"Thyroid dysfunction and diabetes mellitus: two closely associated disorders [J]","volume":"40","author":"Biondi","year":"2019","journal-title":"Endocr Rev"},{"key":"R3-20250504","first-page":"1277","article-title":"Thyroid and Islet autoantibodies predict autoimmune thyroid disease at type 1 diabetes diagnosis [J]","volume":"02","author":"Jonsdottir","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-20250504","first-page":"737","article-title":"Relation between type 2 diabetes mellitus and thyroid disease [J]","volume":"119","author":"Broz","year":"2018","journal-title":"Bratisl Lek Listy"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"03","DOI":"10.2337\/diaclin.34.1.3","article-title":"Standards of medical care in diabetes-2016 abridged for primary care providers [J]","volume":"34","year":"2016","journal-title":"Clin Diabetes"},{"key":"R6-20250504","first-page":"2811","article-title":"Relativity study of insulin-like growth factor 1, insulin resistance and type 2 diabetes with hypothyroidism [J]","volume":"22","author":"Yan","year":"2019","journal-title":"Chin Gen Pract"},{"key":"R7-20250504","first-page":"1534","article-title":"Study on the relationship between the expression level of serum zinc a2 glycoprotein and type 2 diabetes mellitus complicated with hyperuricemia [J]","volume":"19","author":"Song","year":"2017","journal-title":"J Chin Physician"},{"key":"R8-20250504","first-page":"59","article-title":"Correlation between serum nesfatin-1 level and pancreatic (-cell function in patients with type 2 diabetes and subclinical hypothyroidism [J]","volume":"26","author":"Cai","year":"2018","journal-title":"Chin J Prevent Control Chronic Non-Commun Dis"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"51719","DOI":"10.18632\/oncotarget.18514","article-title":"Insulin-like growth factor-1 is a negative modulator of glucagon secretion [J]","volume":"8","author":"Mancuso","year":"2017","journal-title":"Oncotarget"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation [J]","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"R12-20250504","first-page":"967","article-title":"Chinese Society of Endocrinology. Guidelines for the diagnosis and treatment of hypothyroidism [J]","volume":"46","year":"2007","journal-title":"Chin J Intern Med"},{"key":"R13-20250504","first-page":"452","article-title":"The changes and relationship of serum adiponectin and homeostasis model assessment-2 of insulin resistance in newly-diagnosed type 2 diabetic patients accompanied with hypertension [J]","volume":"23","author":"Chen","year":"2015","journal-title":"Chin J Hypertens"},{"key":"R14-20250504","first-page":"374","article-title":"Effects of metformin on the serum nesfatin-1 and liver steatosis in type 2 diabetic patients with nonalcoholic fatty liver disease [J]","author":"Guo","year":"2014","journal-title":"J Diff Complicated Cases"},{"key":"R15-20250504","first-page":"06","article-title":"Type 2 diabetes and thyroid disease [J]","volume":"12","author":"Pei","year":"2016","journal-title":"J Pract Diabetol"},{"key":"R16-20250504","first-page":"2312","article-title":"The expression and significance of lipid metabolism indexes and serum hs-CRP levels in type 2 diabetic patients with subclinical hypothyroidism [J]","volume":"34","author":"Yang","year":"2017","journal-title":"J Clin Res"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.2337\/diacare.27.11.2682","article-title":"The impact of abnormalities in IGF and inflammatory systems on the metabolic syndrome [J]","volume":"27","author":"Kaushal","year":"2004","journal-title":"Diabetes Care"},{"key":"R18-20250504","first-page":"1998","article-title":"Relationship between insulin-like growth factor-1 and insulin resistance in type 2 diabetic patients with nonalcoholic fatty liver disease [J]","volume":"12","author":"Zhang","year":"2012","journal-title":"Prog Mod Biomed"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/CJP.CJP_50_19","article-title":"Effects of cannabinoid modulation on hypothalamic nesfatin-1 and insulin resistance [J]","volume":"62","author":"Kaya","year":"2019","journal-title":"Chin J Physiol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1677\/JOE-09-0254","article-title":"Nucleobindin-2\/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state [J]","volume":"204","author":"Foo","year":"2010","journal-title":"J Endocrinol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bbrc.2014.12.065","article-title":"Paraventricular NUCB2\/nesfatin-1 is directly targeted by leptin and mediates its anorexigenic effect [J]","volume":"456","author":"Darambazar","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"R22-20250504","first-page":"933","article-title":"The correlation between serum nesfatin-1 and atherosclerosis in patients with primary hypothyroidism [J]","volume":"24","author":"Cai","year":"2016","journal-title":"Chin J Prev Control Chronic Non-Commun Dis"},{"key":"R23-20250504","first-page":"1096","article-title":"Relationship between metabolic syndrome risk factors and zinc (2-glycoprotein [J]","volume":"31","author":"Yang","year":"2015","journal-title":"J Changchun Coll Tradit Chin Med"},{"key":"R24-20250504","first-page":"102","article-title":"Changes of serum ZAG (zinc-(2-glycoprotein) level and its relative factors in type 2 diabetic patients [J]","volume":"20","author":"Xie","year":"2012","journal-title":"Chin J Diabetes"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0030-1265226","article-title":"Growth factor receptors gene expression and Akt phosphorylation in benign human thyroid nodules are unaffected by chronic thyrotropin suppression [J]","volume":"43","author":"Sponziello","year":"2011","journal-title":"Horm MetabRes"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:45:53Z","timestamp":1746337553000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":24,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025432","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,16]]},"assertion":[{"value":"2020-10-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}